{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:12:20Z","timestamp":1778760740226,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020828","name":"Royan Institute for Stem Cell Biology and Technology","doi-asserted-by":"publisher","award":["400000212"],"award-info":[{"award-number":["400000212"]}],"id":[{"id":"10.13039\/100020828","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bahar Tashkhis Teb Co.","award":["BT0011B75"],"award-info":[{"award-number":["BT0011B75"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11951-3","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:49:50Z","timestamp":1778759390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting PCSK9, APOB, and CETP at the Transcriptome Level by hsa-miR-30b-3p Reduces LDL-Associated Protein in Huh-7 Cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Hani","family":"Keshavarz Alikhani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Hendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Rismani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Piryaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6528-3687","authenticated-orcid":false,"given":"Hossein","family":"Baharvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-4366","authenticated-orcid":false,"given":"Massoud","family":"Vosough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"13","key":"11951_CR1","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","volume":"34","author":"GK Hovingh","year":"2013","unstructured":"Hovingh GK, Davidson MH, Kastelein JJ, O\u2019Connor AM (2013) Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J 34(13):962\u2013971","journal-title":"Eur Heart J"},{"key":"11951_CR2","doi-asserted-by":"crossref","unstructured":"Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M et al (2023) 2023 update on European atherosclerosis society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J 44(25):2277\u20132291","DOI":"10.1093\/eurheartj\/ehad197"},{"key":"11951_CR3","unstructured":"Warden BA, Fazio S, Shapiro MD (2024) Familial hypercholesterolemia: genes and beyond. Endotext [Internet]"},{"key":"11951_CR4","unstructured":"Trinder ME (2021) Plasma lipoproteins: genetic influences and relevance to atherosclerotic and infectious diseases. University of British Columbia"},{"key":"11951_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01792-7","volume":"18","author":"PE Penson","year":"2020","unstructured":"Penson PE, Pirro M, Banach M (2020) LDL-C: lower is better for longer\u2014even at low risk. BMC Med 18:1\u20136","journal-title":"BMC Med"},{"key":"11951_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-021-00926-3","volume":"23","author":"H Cohen","year":"2021","unstructured":"Cohen H, Stefanutti C, Bosco MMSRGPDSDGCMKWBBBABFMG (2021) Current approach to the diagnosis and treatment of heterozygote and homozygous FH children and adolescents. Curr Atheroscler Rep 23:1\u201314","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"11951_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/endrev\/bnab035","volume":"43","author":"NG Seidah","year":"2022","unstructured":"Seidah NG, Prat A (2022) The multifaceted biology of PCSK9. Endocr Rev 43(3):558\u2013582","journal-title":"Endocr Rev"},{"issue":"7","key":"11951_CR8","doi-asserted-by":"publisher","first-page":"e24552","DOI":"10.1002\/jcla.24552","volume":"36","author":"R Chen","year":"2022","unstructured":"Chen R, Lin S, Chen X (2022) The promising novel therapies for familial hypercholesterolemia. J Clin Lab Anal 36(7):e24552","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"11951_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41569-018-0107-8","volume":"16","author":"MS Sabatine","year":"2019","unstructured":"Sabatine MS (2019) PCSK9 inhibitors: clinical evidence and implementation. Nat reviews Cardiol 16(3):155\u2013165","journal-title":"Nat reviews Cardiol"},{"issue":"1","key":"11951_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40256-015-0153-0","volume":"16","author":"GM Keating","year":"2016","unstructured":"Keating GM (2016) Evolocumab: a review in hyperlipidemia. Am J Cardiovasc Drugs 16(1):67\u201378","journal-title":"Am J Cardiovasc Drugs"},{"key":"11951_CR11","unstructured":"Update NE (2018) Alirocumab for Treatment of High Cholesterol: Effectiveness and Value. Institute for Clinical and Economic Review. :1"},{"key":"11951_CR12","unstructured":"Feingold KR (2024) Cholesterol lowering drugs. Endotext [Internet]"},{"key":"11951_CR13","unstructured":"Fahey KM The efficacy and cost-effectiveness of evolocumab in the prevention of cardiovascular disease 2018"},{"issue":"2","key":"11951_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3390\/pharmaceutics15020323","volume":"15","author":"\u0141 Wo\u0142owiec","year":"2023","unstructured":"Wo\u0142owiec \u0141, Osiak J, Wo\u0142owiec A, Wijata A, Grze\u015bk E, Kozakiewicz M et al (2023) Inclisiran\u2014safety and effectiveness of small interfering RNA in inhibition of PCSK-9. Pharmaceutics 15(2):323","journal-title":"Pharmaceutics"},{"issue":"2","key":"11951_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM199801083380203","volume":"338","author":"JA Kuivenhoven","year":"1998","unstructured":"Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV et al (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med 338(2):86\u201393","journal-title":"N Engl J Med"},{"issue":"11","key":"11951_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.14348\/molcells.2014.0265","volume":"37","author":"H Mabuchi","year":"2014","unstructured":"Mabuchi H, Nohara A, Inazu A (2014) Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors. Mol Cells 37(11):777\u2013784","journal-title":"Mol Cells"},{"issue":"14","key":"11951_CR17","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1093\/cvr\/cvab350","volume":"118","author":"NS Nurmohamed","year":"2022","unstructured":"Nurmohamed NS, Ditmarsch M, Kastelein JJ (2022) Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents? Cardiovascular Res 118(14):2919\u20132931","journal-title":"Cardiovascular Res"},{"issue":"10","key":"11951_CR18","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1080\/07391102.2017.1363661","volume":"36","author":"Z Yang","year":"2018","unstructured":"Yang Z, Cao Y, Hao D, Yuan X, Zhang L, Zhang S (2018) Binding profiles of cholesterol ester transfer protein with current inhibitors: a look at mechanism and drawback. J Biomol Struct Dynamics 36(10):2567\u20132580","journal-title":"J Biomol Struct Dynamics"},{"issue":"3","key":"11951_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1161\/ATVBAHA.116.307122","volume":"37","author":"J-C Tardif","year":"2017","unstructured":"Tardif J-C, Rhainds D, Rh\u00e9aume E, Dub\u00e9 M-P (2017) CETP: pharmacogenomics-based response to the CETP inhibitor dalcetrapib. Arterioscler Thromb Vasc Biol 37(3):396\u2013400","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"11951_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11883-024-01231-5","volume":"26","author":"B Chang","year":"2024","unstructured":"Chang B, Laffin LJ, Sarraju A, Nissen SE (2024) Obicetrapib\u2014the rebirth of CETP inhibitors? Curr Atheroscler Rep 26(10):603\u2013608","journal-title":"Curr Atheroscler Rep"},{"issue":"11","key":"11951_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrcardio.2017.156","volume":"14","author":"MV Holmes","year":"2017","unstructured":"Holmes MV, Smith GD (2017) Revealing the effect of CETP inhibition in cardiovascular disease. Nat Reviews Cardiol 14(11):635\u2013636","journal-title":"Nat Reviews Cardiol"},{"issue":"8","key":"11951_CR22","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1080\/07391102.2019.1630319","volume":"38","author":"T Kosti\u0107","year":"2020","unstructured":"Kosti\u0107 T, Deljanin Ili\u0107 M, Peri\u0161i\u0107 Z, Mili\u0107 D, \u0110or\u0111evi\u0107 M, Golubovi\u0107 M et al (2020) Design and development of novel therapeutics for coronary heart disease treatment based on cholesteryl ester transfer protein inhibition\u2013in silico approach. J Biomol Struct Dynamics 38(8):2304\u20132313","journal-title":"J Biomol Struct Dynamics"},{"key":"11951_CR23","doi-asserted-by":"crossref","unstructured":"Finkel JB, Duffy D (2013) ACC\/AHA cholesterol treatment guideline: paradigm shifts in managing atherosclerotic cardiovascular disease risk. Trends in cardiovascular medicine. 2015;25(4):340\u20137","DOI":"10.1016\/j.tcm.2014.10.015"},{"key":"11951_CR24","doi-asserted-by":"crossref","unstructured":"Santos RD, Raal FJ, Catapano AL, Witztum JL, Steinhagen-Thiessen E, Tsimikas S (2015) Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein (a) in various populations with hypercholesterolemia: results of 4 phase III trials. Arteriosclerosis, thrombosis, and vascular biology. 35(3):689\u2013699","DOI":"10.1161\/ATVBAHA.114.304549"},{"key":"11951_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40265-019-01114-z","volume":"79","author":"F Fogacci","year":"2019","unstructured":"Fogacci F, Ferri N, Toth PP, Ruscica M, Corsini A, Cicero AF (2019) Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials. Drugs 79:751\u2013766","journal-title":"Drugs"},{"issue":"5","key":"11951_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrcardio.2011.2","volume":"8","author":"A Brautbar","year":"2011","unstructured":"Brautbar A, Ballantyne CM (2011) Pharmacological strategies for lowering LDL cholesterol: statins and beyond. Nat Reviews Cardiol 8(5):253\u2013265","journal-title":"Nat Reviews Cardiol"},{"key":"11951_CR27","doi-asserted-by":"crossref","unstructured":"Arca M, D\u2019Erasmo L, Cuchel M, Blom DJ, Cegla J, Duell PB et al (2025) Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data. J Clin Lipidol","DOI":"10.1016\/j.jacl.2025.03.015"},{"key":"11951_CR28","doi-asserted-by":"publisher","first-page":"204173142210885","DOI":"10.1177\/20417314221088509","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Liu S, Tan J, Wei L, Wu D, Gao S et al (2022) Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies. J tissue Eng 13:20417314221088509","journal-title":"J tissue Eng"},{"issue":"2","key":"11951_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3803\/EnM.2021.964","volume":"36","author":"B Tomlinson","year":"2021","unstructured":"Tomlinson B, Patil NG, Fok M, Lam CWK (2021) Role of PCSK9 inhibitors in patients with familial hypercholesterolemia. Endocrinol Metabolism 36(2):279\u2013295","journal-title":"Endocrinol Metabolism"},{"issue":"6","key":"11951_CR30","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.fertnstert.2013.10.042","volume":"101","author":"JM Moreno-Moya","year":"2014","unstructured":"Moreno-Moya JM, Vilella F, Sim\u00f3n C (2014) MicroRNA: key gene expression regulators. Fertil Steril 101(6):1516\u20131523","journal-title":"Fertil Steril"},{"key":"11951_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fgene.2017.00189","volume":"8","author":"P Naeli","year":"2017","unstructured":"Naeli P, Mirzadeh Azad F, Malakootian M, Seidah NG, Mowla SJ (2017) Post-transcriptional regulation of PCSK9 by miR-191, miR-222, and miR-224. Front Genet 8:189","journal-title":"Front Genet"},{"issue":"1","key":"11951_CR32","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/ncomms8466","volume":"6","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zalzala M, Xu J, Li Y, Yin L, Zhang Y (2015) A metabolic stress-inducible miR-34a-HNF4\u03b1 pathway regulates lipid and lipoprotein metabolism. Nat Commun 6(1):7466","journal-title":"Nat Commun"},{"issue":"7","key":"11951_CR33","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/nm.3200","volume":"19","author":"J Soh","year":"2013","unstructured":"Soh J, Iqbal J, Queiroz J, Fernandez-Hernando C, Hussain MM (2013) MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat Med 19(7):892\u2013900","journal-title":"Nat Med"},{"issue":"2","key":"11951_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/bph.16412","volume":"182","author":"M Sopi\u0107","year":"2025","unstructured":"Sopi\u0107 M, Vladimirov S, Munjas J, Miti\u0107 T, Hall IF, Jusic A et al (2025) Targeting noncoding RNAs to treat atherosclerosis. Br J Pharmacol 182(2):220\u2013245","journal-title":"Br J Pharmacol"},{"key":"11951_CR35","doi-asserted-by":"crossref","unstructured":"Kruger NJ (2009) The Bradford method for protein quantitation. protein protocols Handb. :17\u201324","DOI":"10.1007\/978-1-59745-198-7_4"},{"issue":"1","key":"11951_CR36","doi-asserted-by":"publisher","first-page":"17675","DOI":"10.1038\/srep17675","volume":"5","author":"G-Q Wu","year":"2015","unstructured":"Wu G-Q, Wang X, Zhou H-Y, Chai K-Q, Xue Q, Zheng A-H et al (2015) Evidence for transcriptional interference in a dual-luciferase reporter system. Sci Rep 5(1):17675","journal-title":"Sci Rep"},{"issue":"6","key":"11951_CR37","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/1087057112439606","volume":"17","author":"CM Connelly","year":"2012","unstructured":"Connelly CM, Thomas M, Deiters A (2012) High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function. J BioMol Screen 17(6):822\u2013828","journal-title":"J BioMol Screen"},{"key":"11951_CR38","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1007\/s00018-015-1922-2","volume":"72","author":"F Afonso-Grunz","year":"2015","unstructured":"Afonso-Grunz F, M\u00fcller S (2015) Principles of miRNA\u2013mRNA interactions: beyond sequence complementarity. Cell Mol Life Sci 72:3127\u20133141","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"11951_CR39","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1261\/rna.1082708","volume":"14","author":"D Didiano","year":"2008","unstructured":"Didiano D, Hobert O (2008) Molecular architecture of a miRNA-regulated 3\u2032 UTR. RNA 14(7):1297\u20131317","journal-title":"RNA"},{"issue":"17","key":"11951_CR40","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.4161\/cc.5.17.3133","volume":"5","author":"GJ Hurteau","year":"2006","unstructured":"Hurteau GJ, Spivack SD, Brock GJ (2006) Potential mRNA degradation targets of hsa-miR-200c. Cell Cycle 5(17):1951\u20131956","journal-title":"Cell Cycle"},{"issue":"7308","key":"11951_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"H Guo","year":"2010","unstructured":"Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835\u2013840","journal-title":"Nature"},{"issue":"50","key":"11951_CR42","doi-asserted-by":"publisher","first-page":"29916","DOI":"10.1074\/jbc.270.50.29916","volume":"270","author":"F Gaudet","year":"1995","unstructured":"Gaudet F, Ginsburg GS (1995) Transcriptional Regulation of the Cholesteryl Ester Transfer Protein Gene by the Orphan Nuclear Hormone Receptor Apolipoprotein AI Regulatory Protein-1 (\u2217). J Biol Chem 270(50):29916\u201329922","journal-title":"J Biol Chem"},{"issue":"4","key":"11951_CR43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/MOL.0000000000000094","volume":"25","author":"L Goedeke","year":"2014","unstructured":"Goedeke L, Aranda JF, Fern\u00e1ndez-Hernando C (2014) microRNA regulation of lipoprotein metabolism. Curr Opin Lipidol 25(4):282\u2013288","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"11951_CR44","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/nar\/gkab1256","volume":"50","author":"A Kilikevicius","year":"2021","unstructured":"Kilikevicius A, Meister G, Corey DR (2021) Reexamining assumptions about miRNA-guided gene silencing. Nucleic Acids Res 50(2):617\u2013634","journal-title":"Nucleic Acids Res"},{"key":"11951_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne) 9:402","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11951_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-nutr-081810-160756","volume":"31","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Rayner KJ, Su\u00e1rez Y, Fern\u00e1ndez-Hernando C (2011) The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu Rev Nutr 31:49\u201363","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"11951_CR47","doi-asserted-by":"publisher","first-page":"e31930","DOI":"10.1371\/journal.pone.0031930","volume":"7","author":"AC Papp","year":"2012","unstructured":"Papp AC, Pinsonneault JK, Wang D, Newman LC, Gong Y, Johnson JA et al (2012) Cholesteryl Ester Transfer Protein (CETP) Polymorphisms Affect mRNA Splicing, HDL Levels, and Sex-Dependent Cardiovascular Risk. PLoS ONE 7(3):e31930","journal-title":"PLoS ONE"},{"issue":"6","key":"11951_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41580-021-00354-w","volume":"22","author":"P Agbu","year":"2021","unstructured":"Agbu P, Carthew RW (2021) MicroRNA-mediated regulation of glucose and lipid metabolism. Nat Rev Mol Cell Biol 22(6):425\u2013438","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"11951_CR49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12944-020-01261-3","volume":"19","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Ma X-F, Dong M-Z, Tan J, Zhang J, Zhuang L-K et al (2020) MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line. Lipids Health Dis 19(1):76","journal-title":"Lipids Health Dis"},{"issue":"7","key":"11951_CR50","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1194\/jlr.R083451","volume":"59","author":"A Sirwi","year":"2018","unstructured":"Sirwi A, Hussain MM (2018) Lipid transfer proteins in the assembly of apoB-containing lipoproteins. J Lipid Res 59(7):1094\u20131102","journal-title":"J Lipid Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11951-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11951-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11951-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:50:07Z","timestamp":1778759407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11951-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11951"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11951-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"765"}}